Desmopressin
FDA-approved desmopressin (DDAVP) for diabetes insipidus (a water-balance condition), enuresis, and selected bleeding uses.
What it's for
FDA-approved desmopressin (DDAVP) for diabetes insipidus (a water-balance condition), enuresis, and selected bleeding uses.
What it's for
Desmopressin is a synthetic analog of vasopressin modified for greater V2 selectivity and longer action. Treats central diabetes insipidus, primary nocturnal enuresis, and increases factor VIII/von Willebrand factor (a clotting helper) in mild hemophilia A and type 1 von Willebrand disease as labeled.
What it does for the body
Treats central diabetes insipidus, primary nocturnal enuresis, and increases factor VIII/von Willebrand factor (a clotting helper) in mild hemophilia A and type 1 von Willebrand disease as labeled. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
V2 receptors (lock-and-key landing spots on cells) activation in kidney concentrates urine; in endothelium it releases von Willebrand factor (a clotting helper) and factor VIII. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Desmopressin has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Heart research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Desmopressin — FDA.gov search
- ClinicalTrials.gov search: Desmopressin — U.S. clinical trials registry
- Drugs@FDA search: Desmopressin — FDA drug database (if approved)
- PubMed search: Desmopressin — NCBI PubMed
- PubMed Central search: Desmopressin — NCBI PMC